SOC Telemed (NASDAQ:TLMD) Sees Large Volume Increase
SOC Telemed, Inc. (NASDAQ:TLMD) shares saw unusually-high trading volume on Tuesday . Approximately 22,617 shares traded hands during trading, a decline of 95% from the previous session’s volume of 442,381 shares.The stock last traded at $6.19 and had previously closed at $6.11.
A number of research analysts have issued reports on the company. Royal Bank of Canada assumed coverage on SOC Telemed in a research report on Thursday, January 28th. They set an “outperform” rating and a $10.00 price target for the company. Credit Suisse Group assumed coverage on SOC Telemed in a research report on Tuesday, February 16th. They set an “outperform” rating and a $11.00 price target for the company. Zacks Investment Research lowered SOC Telemed from a “hold” rating to a “sell” rating in a research report on Saturday, April 3rd. BTIG Research lowered SOC Telemed from a “buy” rating to a “neutral” rating in a research report on Friday, January 15th. Finally, Benchmark assumed coverage on SOC Telemed in a research report on Friday, January 15th. They set a “buy” rating and a $12.00 price target for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company’s stock. SOC Telemed presently has a consensus rating of “Buy” and an average price target of $11.40.
The firm has a 50 day simple moving average of $7.35.
About SOC Telemed (NASDAQ:TLMD)
SOC Telemed, Inc provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's technology platform, Telemed IQ, provides telemedicine programs. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, and teleICU.
Further Reading: FinTech
Receive News & Ratings for SOC Telemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SOC Telemed and related companies with MarketBeat.com's FREE daily email newsletter.